Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nature study: A novel family of antibiotics against tuberculosis and salmonella target pathways active in cancer.

29.11.2007
Researchers have discovered new ways to fight bacterial infections including extensively drug-resistant tuberculosis. The work will be published in the journal Nature on 29 November.

The research led by Dr. Jacques Neefjes from the Netherlands Cancer Institute, with collaboration of Dr. Tom Ottenhoff from the Leiden University Medical Center and Dr. Hermen Overkleeft from the Leiden University Institute of Chemistry, shows that pathways commonly found in cancer cells are also modified by pathogenic bacteria. It is likely that the discovery will lead to new drugs against cancer and tuberculosis.

The Dutch groups have developed chemical compounds which can greatly reduce the bacterial loads within infected human cells (such as Mycobacteria tuberculosis and Salmonella typhimurium). The chemical compounds they generated inhibit PKB/Akt1 enzymes in cells, enzymes which are also upregulated in various cancers. It appears that pathogenic bacteria seize control of PKB/Akt1 to evade immune degradation. Inhibiting the PKB/Akt1 enzyme thus forces the bacteria back into the degradation pathway to be eliminated.

PKB/Akt1 is the focus of cancer research at present since it has been shown to stimulate the growth of cancer cells. Discovering that bacteria utilize PKB/Akt1 in order to survive, sheds some light onto mechanisms that lead to cancer development following chronic bacterial infections in some patients.

“Many anti-cancer drugs originate from antibiotic discovery attempts. Pharmaceutical companies are currently developing specific PKB/Akt1 inhibitors. It is feasible that these inhibitors may well work against bacterial infections also”, says Dr. Jacques Neefjes.

This month, the World Health Organization (WHO) sounded the alarm because of a severe increase in multi and extensively drug-resistant (MDR and XDR) Mycobacterium tuberculosis infected countries. For MDR and XDR infected patients, current antibiotic therapy is inefficient or ineffective. New antibiotic therapies are therefore urgently needed.

This research was supported by the Netherlands Organization for Scientific Research (NWO), the Dutch Cancer Society (KWF) and an EEC network grant.

Frederique Melman | alfa
Further information:
http://www.nki.nl/Research/

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Organ-on-a-chip mimics heart's biomechanical properties

23.02.2017 | Health and Medicine

Light-driven reaction converts carbon dioxide into fuel

23.02.2017 | Life Sciences

Oil and gas wastewater spills alter microbes in West Virginia waters

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>